WO2015030423A1 - Micro-organisme ayant une capacité de production d'acide propionique et composition alimentaire le contenant - Google Patents
Micro-organisme ayant une capacité de production d'acide propionique et composition alimentaire le contenant Download PDFInfo
- Publication number
- WO2015030423A1 WO2015030423A1 PCT/KR2014/007770 KR2014007770W WO2015030423A1 WO 2015030423 A1 WO2015030423 A1 WO 2015030423A1 KR 2014007770 W KR2014007770 W KR 2014007770W WO 2015030423 A1 WO2015030423 A1 WO 2015030423A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- propionic acid
- forage
- acid production
- feed
- products
- Prior art date
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title claims abstract description 77
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 38
- 235000019260 propionic acid Nutrition 0.000 title claims abstract description 35
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 244000005700 microbiome Species 0.000 title abstract description 18
- 239000004459 forage Substances 0.000 claims description 28
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 27
- 241000282849 Ruminantia Species 0.000 claims description 26
- 241000186660 Lactobacillus Species 0.000 claims description 21
- 229940039696 lactobacillus Drugs 0.000 claims description 21
- 210000004877 mucosa Anatomy 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- 239000002699 waste material Substances 0.000 claims description 13
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 claims description 8
- 230000001737 promoting effect Effects 0.000 claims description 7
- 235000013372 meat Nutrition 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 4
- 241000394636 Lactobacillus mucosae Species 0.000 claims description 3
- 239000006227 byproduct Substances 0.000 description 30
- 210000004767 rumen Anatomy 0.000 description 21
- 238000000855 fermentation Methods 0.000 description 18
- 230000004151 fermentation Effects 0.000 description 18
- 239000002609 medium Substances 0.000 description 16
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 150000004665 fatty acids Chemical class 0.000 description 13
- 239000007789 gas Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 244000144972 livestock Species 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000006872 mrs medium Substances 0.000 description 6
- 239000004460 silage Substances 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 5
- 241000186429 Propionibacterium Species 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 239000006041 probiotic Substances 0.000 description 5
- 235000018291 probiotics Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000001540 sodium lactate Substances 0.000 description 5
- 229940005581 sodium lactate Drugs 0.000 description 5
- 235000011088 sodium lactate Nutrition 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000003337 fertilizer Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 229940001447 lactate Drugs 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108020001027 Ribosomal DNA Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241001017228 Selenomonas bovis Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000011095 buffer preparation Methods 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009229 glucose formation Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- -1 sodium lactate Chemical compound 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 238000009461 vacuum packaging Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
- A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Definitions
- the present invention relates to a microorganism having a proonic acid producing ability and a forage composition comprising the same.
- Volatile fatty acids are the most important end products of carbohydrate breakdown in the rumen. Volatile fatty acids are an important source of energy (70%) for ruminants and also affect the protein and fat content of milk.
- the main volatile fatty acids produced by the metabolism in the rumen are three types of acetic acid, propionic acid and butyric acid, depending on the type of feed fed and the degree of digestion. Only propionic acid among volatile fatty acids in ruminants contributes to glucose synthesis, and quantitatively glucose is a very important single precursor. Propionic acid makes up 18-20% of the total volatile fatty acids and is converted to blood sugar in the liver to provide energy and used for lactose synthesis. Increasing propionic acid increases blood flow in ruminant epithelial cells, stimulates angiogenesis and increases epithelial cells, promotes the growth of ruminants, including cattle, and improves meat quality.
- Fiber is the most abundant energy source on the planet. However, at present, a large part of the survey fee usage in Korea depends on imports. The high dependence on imports of forages is also a task that must be resolved in order to secure the competitiveness of domestic livestock farmers. After mushroom production, various attempts have been made to utilize resources such as fiber-rich waste media as byproducts.
- Korean Patent No. 1144473 relates to a method for preparing fermentation fertilizer for livestock using mushroom by-products as a main raw material, and is characterized by fermentation by adding lactic acid bacteria, Bacillus subtilis and yeast bacteria used as probiotics to mushroom waste medium.
- Korean Patent No. 1138934 relates to a method for producing a pig feed using a waste mushroom medium, characterized in that the fermentation using a complex microbial fermentation agent that does not contain a microorganism having a propioic acid producing ability.
- the present inventors conducted a study on the feed for promoting the ruminant feed, the fermentation of the fertilizer in the rumen to increase the production of propioic acid and thereby the present invention based on a microorganism having a propionic acid production capacity that can promote the fattening Completed.
- An object of the present invention is to provide a ruminant microorganism having a propionic acid production capacity.
- the present invention also aims to provide a forage composition having an excellent fattening promoting effect.
- One aspect of the invention provides a microorganism having a propionic acid production ability isolated from the rumen.
- the microorganism is Lactobacillus mucosae KCCM11440P.
- KCCM11440P in Lactobacillus mucosa has the 16S rRNA nucleotide sequence of SEQ ID NO: 1 and was identified based on this sequence. 1 shows a phylogenetic tree based on 16S rRNA sequences.
- Propionic acid is the most important product of carbohydrate breakdown in the rumen, which is converted from ruminant liver to glucose to promote ruminant fattening and contribute to meat improvement.
- KCCM11440P Lactobacillus mucosa isolated from ruminant on the basis of propionic acid production capacity, KCCM11440P was grown in MRS medium, especially in medium added with vitamin B 12 or sodium lactate was confirmed to have high propion production capacity.
- Another aspect of the invention provides a forage composition comprising Lactobacillus mucosa KCCM11440P.
- the term "irradiant composition” refers to a feed composition having a high fiber content, low fat, protein, starch and the like, such as grasses, hay, silage, and the like.
- the fertilizer composition according to one aspect of the present invention includes KCCM11440P in Lactobacillus mucosa having propionic acid producing ability, thereby increasing the production of propionic acid during fermentation of the fertilizer in the rumen, thereby promoting the fattening of ruminants and improving meat quality.
- propionic acid is the only volatile fatty acid produced in the rumen, it is converted into glucose and contributes to energy metabolism. Thus, promotion of the fat of ruminants including cattle is determined by propionic acid produced in the rumen.
- the forage composition comprises mushroom waste medium.
- Mushroom waste medium refers to a medium obtained by using a sawdust, the main raw material is a sawdust, a secondary material is obtained by using a culture medium for the culture of mushrooms.
- Sawdust in mushroom waste media is used as a carbon source by fibrinolytic microorganisms in the rumen.
- KCCM11440P in Lactobacillus mucosa can be cultured in mushroom lung medium to increase propionic acid production, thereby promoting the rearing of ruminants.
- the mushroom waste medium can be used as a feedstock having excellent digestibility since the waste medium obtained after decomposition by the fibrinolytic bacteria of mushrooms is used as a raw material.
- the forage composition comprises at least one of vitamin B 12 and lactate.
- Lactobacillus mucosa KCCM11440P significantly increases propionic acid production when supplemented with vitamin B 12 or lactate, such as sodium lactate, in the medium. Therefore, the inclusion of at least one of vitamin B 12 and lactate in the forage composition increases propioic acid production, thereby promoting fattening.
- the forage composition promotes the fattening of ruminants.
- Lactobacillus mucosa which contains propioic acid producing ability, contains KCCM11440P, thereby increasing propioic acid production in the rumen, thereby promoting the rearing of ruminants and contributing to improved meat quality.
- the forage composition may further comprise a probiotic.
- Antibiotics are inevitable when raising livestock, but probiotics are widely used due to serious problems caused by misuse. Probiotics contribute to the uptake of beneficial microorganisms in the intestines of animals, thereby inhibiting the growth of pathogenic microorganisms, preventing the occurrence of diseases, and increasing the productivity of livestock.
- beneficial microorganisms are lactic acid bacteria, subtilis bacteria, yeasts and the like. Lactic acid bacteria produce organic acids, lower the pH to inhibit harmful bacteria that are weak to acid, enhance the activity of digestive enzymes, and in particular, reduce the frequency of diarrhea.
- Bacillus subtilis produces enzymes that break down high-active carbohydrates, proteins, and lipids, thereby enhancing feed digestion and absorption in the intestine, improving feed efficiency, and reducing stress from digestion, making livestock growth easier. In addition, it has a formal effect, strengthening the intestines of livestock and preventing disease.
- yeast is present in a form that can be easily digested in the digestive tract of the livestock, by producing a natural flavor component such as alcohol, glutamic acid to enhance the palatability of the feed of the livestock.
- the forage composition may be provided mixed with a general feed.
- the forage composition may be mixed with a commercially formulated feed in a ratio of 1: 1 and fed to ruminants twice a day.
- Appropriate mixing ratios, feeding amount and feeding frequency can be easily determined by those skilled in the art in consideration of the age, weight, health status, etc. of the subject ruminant.
- Another aspect of the present invention provides a method of raising a ruminant, the method comprising feeding a forage comprising KCCM11440P to Lactobacillus mucosa.
- the forage may include mushroom waste medium as a main component.
- the forage may further comprise a probiotic.
- the forage may further comprise one or more of vitamin B 12 and sodium lactate.
- the feed may be fed by mixing with a conventional blended feed.
- ruminants may be, but are not limited to, cattle, sheep, goats, and deer.
- Lactobacillus mucosa KCCM11440P and a forage composition comprising the same according to one embodiment of the present invention increases the propioic acid production in the rumen of ruminants thereby resulting in excellent fattening and meat improvement.
- 1 is a phylogenetic tree based on Lactobacillus mucosa of the present invention based on 16S rRNA gene of KCCM11440P.
- Figure 2 shows the dry matter loss of fermented feed, bran, mushroom by-products, and brewing by-products with time of incubation.
- Bacteria cultured from rumen juice were diluted to 10 ⁇ 3 to 10 ⁇ 9 per ml of medium and inoculated in Hungate roll tubes, followed by incubation for 24 to 48 hours. Cultured single colonies were isolated and incubated at 120 rpm for 24 hours after inoculation in liquid medium (MRS). All cultures were performed anaerobic at 37 ° C. (Lee, et al., Applied Microbiology and Biotechnology, Vol. 58, pp. 663-668, 2002), and all media and buffers used (Bryant and Burkey, Journal of Dairy). Science, Vol. 82, pp. 780-787, 1953) were sterilized at 121 ° C. for 15 minutes and O 2 and N 2 gases were used.
- PCR reaction was performed using 27F primer (AGAGTTTGATCMTGGCTCAG) and 1492R primer (GGTTACCTTGTTACGACTT) for amplification of the gene encoding 16S rRNA.
- PCR conditions consisted of 32 cycles of a cycle consisting of an initial denaturation step of 5 min at 94 ° C., 45 sec denaturation at 94 ° C., 45 sec annealing at 65 ° C., and 1 min elongation at 72 ° C., and 10 min at 72 ° C. It was kidney.
- the amplified ribosomal DNA was analyzed for similarity by ARDRA (Amplified Ribosomal DNA Restriction Analysis) method.
- ARDRA Analog Ribosomal DNA Restriction Analysis
- the PCR products and the HaeIII HhaI restriction enzymes (Takara, Japan) at 37 °C for 5 hours, and were separated for 80 minutes the obtained DNA sample as a metaphor 170v through the electrophoresis using a gel with agar. Thereafter, visualization was performed using a Kodak Gel Logic 200 imaging system (Eastman Kodak Company, Rochester, NY, USA), and bands obtained from ARDRA were purified using a QIA quick PCR Purification Kit.
- the purified 16S rDNA PCR product was identified by SEQ ID NO: 1 by analyzing the nucleotide sequence in Macrogen (Korea).
- the analyzed sequencing information was combined using SeqMan program (DNA Star, Lasergene software, Madison, WI, USA), and the base sequences were NCBI ( http://www.ncbi.nlm.nih.gov/BLAST ) and EzTaxon Comparison was made using the BLAST program at GeneBank ( http://147.47.212.35:8080/index.jsp ).
- Approximate phylogenetic classification was determined using CLUSTRAL W version 1.6 to compare sequences with the nearest species.
- the phylogenetic tree was prepared as disclosed in Kimura (1980) using a neighbor-joining (NJ) method with pair-wise gap removal. Finally, the two-parameter NJ method in the PHYLIP package was used, and the bootstrap analysis method was used to collect 1000 times more data to evaluate the stability of the tree. Only bootstrap values of 50% or more are shown. 1 shows the phylogenetic tree created.
- the isolated strain showed 96% similarity to S32 (T) in Lactobacillus mucosa. Based on this, the isolated strain was named BR-PP to Lactobacillus mucosa, and it was deposited with the Korea Microorganism Conservation Center on July 26, 2013 and received an accession number of KCCM11440P.
- Propionibacterium axidipropionis showed high propionic acid production after 144 hours. In addition, Propionibacterium axidipropionis showed conditional anaerobic unlike other propionic acid producing strains that are either complete or essential anaerobic. High propionic acid production and conditional anaerobic propionibacterium axidipropionis were selected as the propionic acid producing standard microorganisms and used as controls.
- the propionic acid production capacity of Lactobacillus mutosa isolated and identified in Example 1 was evaluated.
- the agar was cultured in anaerobic state for 48 hours in MRS medium.
- the medium was placed in a Hungate tube and autoclaved at 121 ° C. for 15 minutes after filling with pH 6.5, O 2 -free 20% CO 2 -80% N 2 gas.
- Biotin 0.5 mg / L
- vitamin B 12 50 ⁇ g / L
- glycerol (2%) was added to agar of MRS medium to confirm the effect on propionic acid production capacity, respectively.
- the control for the evaluation of propionic acid production capacity was propionibacterium acidipropioni selected in Example 1.
- Samples were taken at 24, 48 and 72 hours of culture to determine the production of volatile fatty acids, including OD, pH and propionic acid.
- the pH was not measured directly in the incubator but stabilized at the same temperature as room temperature, and then measured using an M503P meter (wrks, Medififield, MA, USA).
- the amount of volatile fatty acid produced was analyzed after centrifugation of the culture for each time period at 1000 ⁇ g 4 ° C. for 10 minutes, and then the supernatant was collected and purified with a 0.2 ⁇ m micro filter.
- HPLC analysis was carried out at 35 ° C. using HPLC (Agilent technolgies 1200 series) equipped with a METACARB87H (Varian, Germany) column, and the UV wavelengths of the detectors were 210 nm and 220 nm.
- the mobile phase solvent was 0.0085 NH 2 SO 4 and the flow rate was 0.6 ml / min.
- Lactobacillus mucosa KCCM11440P produces the highest amount of propionic acid when cultured in MRS medium supplemented with vitamin B 12 or sodium lactate.
- Rumen and buffer were used to evaluate the fermentation effect in the rumen in In Vitro .
- Gastric fluid was collected for in vitro testing using 600 ⁇ 47 kg Holstein cows equipped with rumen fistulas from Sunchon National University farm.
- Hanwoo a domestic animal, is Italian ly grass and rich feed (55% corn, 15% wheat, 8% skim rice, 5% corn gluten feed, 10% soybean meal, 0.2% molasses, calcium carbonate (limestone) ) 2.0%, salt 0.5%, calcium phosphate 1.3%, vitamin-mineral mixture (vitamin A 3000 IU, vitamin D 6000 IU, vitamin E 30 IU, Cu 25 mg, Fe 150 mg, Zn 200 mg, Mn 100 mg, Co 0.5 mg, and I 1.5 mg) 1.0%) was fed twice daily to 2% of body weight in a ratio of 2: 8 and free water was taken.
- Buffer (Hino et al., 1992) is K 2 HPO 4 0.45 g / L , KH 2 PO 4 0.45 g / L, (NH 4) 2 SO 4 0.9 g / L, CaCl 2 ⁇ 2H 2 O 0.12 g / L , Basal media comprising MgSO 4 7H 2 O 0.19 g / L, Trypticase 1.0 g / L, yeast extract 1.0 g / L, cysteine HCl 0.6 g / L (pH 6.9) was prepared.
- Rumen and buffer were mixed at a ratio of 1: 3 (rumen: buffer) and filled with nitrogen gas (N 2 gas).
- N 2 gas nitrogen gas
- Each fermented feed was placed in a 160 ml serum bottle with 2% dry matter, 100 ml of the prepared buffer was kept anaerobic with O 2 free-N 2 , sealed with a rubber stopper and an aluminum cap, and The mixture was incubated at 100 rpm in an anaerobic state (Hattori and Matsui, Anaerobe, Vol. 14, pp. 87-93, (2008)).
- In vitro culture was performed in three replicate experiments for 0, 12, 24, and 48 hours, and pH, total gas evolution, methane, ammonia, and VFA were measured as characteristics of the rumen fermentation.
- the pH was not measured directly in the incubator but stabilized at the same temperature as room temperature, and then measured using an M503P meter (wrks, Medififield, MA, USA).
- the total gas generation amount was stabilized and used EA-6 (Inc, Sun Bee instrument) pressure sensor measuring instrument. After the total gas generation was measured, the generated gas was collected using a vacuum tube to measure the amount of methane and carbon dioxide generated. On the basis of the total gas generation amount obtained for each incubation time, the gas generation amount was estimated by the formula of Qrskov and McDonald (1979).
- the VFA measurement was analyzed after centrifugation of the culture by time incubation at 1000 ⁇ g 4 °C for 10 minutes to extract the supernatant and purified with a 0.2 ⁇ m micro filter.
- HPLC analysis was carried out at 35 ° C. using HPLC (Agilent technolgies 1200 series) equipped with a METACARB87H (Varian, Germany) column, and the UV wavelengths of the detectors were 210 nm and 220 nm.
- the mobile phase solvent was 0.0085 NH 2 SO 4 and the flow rate was 0.6 ml / min.
- Ammonia concentration was measured by centrifuging the sample at 13000rpm and spectroscopy was carried out by developing ammonia in the sample with phenol solution according to the method of Chany and Marbach (Clinical Chemistry, Vol. 8, pp. 130-132, (1962)). Absorbance was measured and measured at 630 nm using a photometer (Spectronics 21D).
- Figure 2 shows the dry matter loss of the fermented feed according to the incubation time.
- a combination of bran and brew by-products or mushroom by-products was used as fermented feed.
- the amount of loss in mushroom by-products was higher than for brewing by-products.
- mushroom byproducts are easier to digest in the rumen than brewing byproducts.
- Silage provides for feed quality and maximum building. Microorganisms in the feed also speed up the fermentation and enhance the results of silage. Therefore, the fermentation effect was measured in vitro by adding microorganisms having propionic acid production capacity.
- Table 4 shows the dry matter (buildings) loss with fermentation incubation time.
- the loss of building by mushroom by-products was lower than by brewing by-products (P ⁇ 0.05).
- the increase in dry matter loss of brewing by-products of silage is indicated by the addition to Lactobacillus mucosa.
- Table 5 shows the VFA production by fermentation. Dry matter loss was observed to be low in mushroom byproducts, while total VFA and propionic acid were high in brewing byproducts. In addition, fermentation by adding Lactobacillus mucosa to the by-product during the treatment showed high propionic acid production and total volatile fatty acids (TVFA). This shows that the acid change of mushroom by-products occurs higher than brewing by-products due to nutritional composition. The large amount of acid produced while silage is produced means that feed is a higher energy source for ruminants.
- Table 6 shows the total gas production, pH, and ammonia nitrogen production by in vitro fermentation of brewing by-products and mushroom by-products.
Abstract
Cette invention concerne un micro-organisme ayant une capacité de production d'acide propionique et une composition alimentaire le contenant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016538843A JP2016533755A (ja) | 2013-08-30 | 2014-08-21 | プロピオン酸の産生能を持つ微生物及びそれを含む粗飼料組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130104520A KR101470995B1 (ko) | 2013-08-30 | 2013-08-30 | 프로피온산 생산능을 갖는 미생물 및 그를 포함하는 조사료 조성물 |
KR10-2013-0104520 | 2013-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015030423A1 true WO2015030423A1 (fr) | 2015-03-05 |
Family
ID=52586905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2014/007770 WO2015030423A1 (fr) | 2013-08-30 | 2014-08-21 | Micro-organisme ayant une capacité de production d'acide propionique et composition alimentaire le contenant |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2016533755A (fr) |
KR (1) | KR101470995B1 (fr) |
WO (1) | WO2015030423A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019506413A (ja) * | 2016-02-25 | 2019-03-07 | カエルス ファーマシューティカルズ ビー.ヴィ. | ビタミンb12欠乏症を予防および/または治療するための組成物および方法 |
CN113575768A (zh) * | 2021-06-23 | 2021-11-02 | 中国农业科学院北京畜牧兽医研究所 | 用于调控反刍动物瘤胃发酵气体产量的组合物及其用途 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040048356A1 (en) * | 2000-11-10 | 2004-03-11 | Marie-Louise Johansson | Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
KR100575522B1 (ko) * | 2003-11-11 | 2006-05-03 | 대한민국 | 옥수수 사일리지 발효용 미생물 첨가제 |
US20090162322A1 (en) * | 2004-05-28 | 2009-06-25 | Markus Rudolph | Oral administration form comprising probiotic bacteria |
KR20110102172A (ko) * | 2010-03-08 | 2011-09-16 | 김중관 | 젖소 또는 육우용 혼합-발효사료 |
US20130084623A1 (en) * | 2010-06-16 | 2013-04-04 | Instytut Biotechnologii Przemysul Ronlno-Spozywczego | Strain of lactobacillus plantarum s, the use of the strain of lactobacillus plantarum s and the preparation for roughages ensiling |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080138461A1 (en) * | 2006-12-11 | 2008-06-12 | Pioneer Hi-Bred International, Inc. | Lactobacillus buchneri strain LN1297 and its use to improve aerobic stability of silage |
WO2008078878A1 (fr) * | 2006-12-22 | 2008-07-03 | Deuk-Sik Lee | Aliments fermentés pour l'élevage de bétail à l'aide de bactéries d'acide lactique et de levures et procédé de traitement associé |
JP2009044976A (ja) * | 2007-08-16 | 2009-03-05 | Meiji Shiryo Kk | 動物の体型改良飼養システム |
JP2011030466A (ja) * | 2009-07-30 | 2011-02-17 | Kamada Kogyo:Kk | 肉牛飼料及びそれを用いた肉牛の肥育方法 |
WO2011071134A1 (fr) * | 2009-12-10 | 2011-06-16 | 明治乳業株式会社 | Composition prophylactique pour infection grippale |
AU2010336620B2 (en) * | 2009-12-25 | 2016-02-04 | Meiji Feed Co., Ltd. | Composition containing bacterium capable of producing propionic acid bacterium, and use thereof |
US20120034198A1 (en) * | 2010-08-04 | 2012-02-09 | Microbios, Inc. | Carriers for storage and delivery of biologics |
-
2013
- 2013-08-30 KR KR20130104520A patent/KR101470995B1/ko not_active IP Right Cessation
-
2014
- 2014-08-21 JP JP2016538843A patent/JP2016533755A/ja not_active Ceased
- 2014-08-21 WO PCT/KR2014/007770 patent/WO2015030423A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040048356A1 (en) * | 2000-11-10 | 2004-03-11 | Marie-Louise Johansson | Use of a strain of lactobacillus reducing the risk factors involved in the metabolic syndrome |
KR100575522B1 (ko) * | 2003-11-11 | 2006-05-03 | 대한민국 | 옥수수 사일리지 발효용 미생물 첨가제 |
US20090162322A1 (en) * | 2004-05-28 | 2009-06-25 | Markus Rudolph | Oral administration form comprising probiotic bacteria |
KR20110102172A (ko) * | 2010-03-08 | 2011-09-16 | 김중관 | 젖소 또는 육우용 혼합-발효사료 |
US20130084623A1 (en) * | 2010-06-16 | 2013-04-04 | Instytut Biotechnologii Przemysul Ronlno-Spozywczego | Strain of lactobacillus plantarum s, the use of the strain of lactobacillus plantarum s and the preparation for roughages ensiling |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019506413A (ja) * | 2016-02-25 | 2019-03-07 | カエルス ファーマシューティカルズ ビー.ヴィ. | ビタミンb12欠乏症を予防および/または治療するための組成物および方法 |
CN113575768A (zh) * | 2021-06-23 | 2021-11-02 | 中国农业科学院北京畜牧兽医研究所 | 用于调控反刍动物瘤胃发酵气体产量的组合物及其用途 |
CN113575768B (zh) * | 2021-06-23 | 2023-09-15 | 中国农业科学院北京畜牧兽医研究所 | 用于调控反刍动物瘤胃发酵气体产量的组合物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
KR101470995B1 (ko) | 2014-12-09 |
JP2016533755A (ja) | 2016-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Konstantinov et al. | Microbial diversity studies of the porcine gastrointestinal ecosystem during weaning transition | |
RU2528859C2 (ru) | Изолированный штамм (варианты), обеспечивающий улучшение состояния здоровья жвачных животных, способ его получения, и способ его введения жвачным животным | |
CN109929773B (zh) | 一株可用于富硒培养的双歧杆菌及其活性蛋白和应用 | |
Miguel et al. | Enhancing butyrate production, ruminal fermentation and microbial population through supplementation with Clostridium saccharobutylicum | |
JP6663977B2 (ja) | バチルスサブチリスとバチルスリケニフォルミスを含む飼料添加剤、前記添加剤を含む飼料組成物及び前記飼料添加剤の製造方法 | |
Kim et al. | Fumarate reductase-producing enterococci reduce methane production in rumen fermentation in vitro | |
WO2019027073A1 (fr) | Additif d'aliments pour animaux contenant bacillus subtilis et bacillus licheniformis, composition d'aliments pour animaux contenant ledit additif et procédé de préparation dudit additif | |
Sadet-Bourgeteau et al. | Equine microbial gastro-intestinal health | |
CN113403227A (zh) | 一株植物乳杆菌及其制备方法和应用 | |
WO2015030423A1 (fr) | Micro-organisme ayant une capacité de production d'acide propionique et composition alimentaire le contenant | |
Azzaz et al. | A newly developed strain of Enterococcus faecium isolated from fresh dairy products to be used as a probiotic in lactating Holstein cows | |
CN107012095B (zh) | 猪结肠微生物组体外模拟培养的发酵参数 | |
CN116445372B (zh) | 提高反刍动物瘤胃氮素转化效率的敏捷乳杆菌及其应用 | |
WO2017222142A1 (fr) | Souche ny1505 de bacillus licheniformis pour la production en masse d'un inhibiteur d'α-glucosidase | |
KR100631857B1 (ko) | 감마아미노부틸산(gaba) 고생산성 균주인락토바실러스 브레비스 오피케이-3 | |
CN109423466A (zh) | 一种复合发酵菌剂及其应用 | |
JP2016533755A5 (fr) | ||
KR20080011901A (ko) | 내산성, 내담즙성의 적응력이 강하고, 병원성 미생물의 생육을 억제하고, 알파-갈락토시데이지 효소를 생산하는 락토바실러스 살리바리우스 에스피 살리바리우스 df20(kctc10942bp) 미생물 | |
Stewart | Lactic acid bacteria in the rumen | |
SUHARTI et al. | Morphological, biochemical, and molecular identification of cellulolytic bacteria isolated from feces of endemic tropical herbivores | |
Onrust et al. | Caecibacterium sporoformans gen. nov., sp. nov., an anaerobic, butyrate-producing, spore-forming bacterium isolated from chicken caecum | |
Marounek et al. | Metabolism and some characteristics of lactobacilli isolated from the rumen of young calves | |
Fujisawa et al. | Influences of Prebio SupportTM (mixture of fermented products of Lactobacillus gasseri OLL2716 and Propionibacterium freudenreichii ET-3) on the composition and metabolic activity of fecal microbiota in calves | |
CN117070419B (zh) | 源于奶牛瘤胃的栖瘤胃肠球菌及其作为饲料添加剂的应用 | |
CN112493366B (zh) | 一种固态发酵断奶仔猪饲料的复合菌剂、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2016538843 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14840685 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14840685 Country of ref document: EP Kind code of ref document: A1 |